Recombinant Tumor Vaccine - Catbrm

Lobuglio, Albert F.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 2U01CA061397-04
• Application #: 2008346
• Study Section: Special Emphasis Panel (SRC (17))
• Project Start: 1996-09-30
• Project End: 2000-07-31
• Budget Start: 1996-09-30
• Budget End: 1997-07-31
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: University of Alabama Birmingham
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 004514360
• City: Birmingham
• State: AL
• Country: United States
• Zip Code: 35294

Publications

Conry, R M; Allen, K O; Lee, S et al. (2000) Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine. Clin Cancer Res 6:34-41

Lee, S W; Li, H; Strong, T V et al. (2000) Development of a polynucleotide vaccine from melanoma antigen recognized by T cells-1 and recombinant protein from melanoma antigen recognized by T cells-1 for melanoma vaccine clinical trials. J Immunother 23:379-86

Rodenburg, C M; Mernaugh, R; Bilbao, G et al. (1998) Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones. Hybridoma 17:1-8